- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
Cytodyn (CYDY) is a leading biotechnology business based in the US. It opened the day at $0.13 after a previous close of $0.12. During the day the price has varied from a low of $0.12 to a high of $0.13. The latest price was $0.12 (25 minute delay). Cytodyn is listed on the OTCQB and employs 9 staff. All prices are listed in US Dollars.
Our top picks for where to buy Cytodyn stock
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you fund a new account within 30 days
- Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%
How to buy Cytodyn stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – CYDY. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Cytodyn stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Cytodyn stock price (OTCQB: CYDY)
Use our graph to track the performance of CYDY stocks over time.Cytodyn shares at a glance
Information last updated 2024-12-21.
| Open | $0.00 |
|---|---|
| High | $0.00 |
| Low | $0.00 |
| Close | $0.00 |
| Previous close | $0.00 |
| Change | $0.00 |
| Change % | N/A% |
| Volume | 0 |
Information last updated 2024-12-18.
| 52-week range | $0.10 - $0.32 |
|---|---|
| 50-day moving average | $0.13 |
| 200-day moving average | $0.15 |
| Wall St. target price | $4.00 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.02 |
Is it a good time to buy Cytodyn stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Cytodyn price performance over time
Historical closes compared with the close of $0.12 from 2024-12-19
| 1 week (2024-12-13) | -14.29% |
|---|---|
| 1 month (2024-11-22) | 0.12 |
| 3 months (2024-09-20) | -25.00% |
| 6 months (2024-06-21) | -14.29% |
| 1 year (2023-12-21) | -45.45% |
|---|---|
| 2 years (2022-12-21) | -42.86% |
| 3 years (2021-12-21) | 1.05 |
| 5 years (2019-12-20) | 0.58 |
Cytodyn financials
| Gross profit TTM | $-20,633,000 |
|---|---|
| Return on assets TTM | -49.45% |
| Return on equity TTM | 0% |
| Profit margin | 0% |
| Book value | $-0.07 |
| Market Capitalization | $158.6 million |
TTM: trailing 12 months
Cytodyn share dividends
We're not expecting Cytodyn to pay a dividend over the next 12 months.
Cytodyn share price volatility
Over the last 12 months, Cytodyn's shares have ranged in value from as little as $0.1 up to $0.32. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (OTCQB average) beta is 1, while Cytodyn's is 0.165. This would suggest that Cytodyn's shares are less volatile than average (for this exchange).
Cytodyn overview
CytoDyn Inc. , a clinical-stage biotechnology company, engages in the development of treatments for multiple therapeutic indications. The company is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19, human immunodeficiency virus (HIV), Metabolic dysfunction-associated steatohepatitis (MASH), and solid tumors in oncology, such as metastatic triple-negative breast cancer. Its leronlimab is currently under phase 2 development for the treatment of NASH, HIV- NASH, and solid tumors, as well as under pre-clinical development for the treatment of HIV-PrEP and HIV-Cure. The company was formerly known as RexRay Corporation. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington.
Frequently asked questions
What percentage of Cytodyn is owned by insiders or institutions?Currently 0.783% of Cytodyn shares are held by insiders and 0.033% by institutions. How many people work for Cytodyn?
Latest data suggests 9 work at Cytodyn. When does the fiscal year end for Cytodyn?
Cytodyn's fiscal year ends in May. Where is Cytodyn based?
Cytodyn's address is: 1111 Main Street, Vancouver, WA, United States, 98660 What is Cytodyn's ISIN number?
Cytodyn's international securities identification number is: US23283M1018 What is Cytodyn's CUSIP number?
Cytodyn's Committee on Uniform Securities Identification Procedures number is: 23283M101
More resources on Finder
More guides on Finder
-
How to buy Merck-and-Company stock (MRK)
Steps to owning and managing MRK, with 24-hour and historical pricing before you buy.
-
How to buy Eli Lilly and Company stock (LLY)
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
-
How to buy Intuitive Surgical stock (ISRG)
Steps to owning and managing ISRG, with 24-hour and historical pricing before you buy.
-
How to buy Vertex Pharmaceuticals stock (VRTX)
Steps to owning and managing VRTX, with 24-hour and historical pricing before you buy.
-
How to buy McKesson Corporation stock (MCK)
Steps to owning and managing MCK, with 24-hour and historical pricing before you buy.
-
How to buy UnitedHealth Group Incorporated stock (UNH)
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
-
How to buy Amgen stock (AMGN)
Steps to owning and managing AMGN, with 24-hour and historical pricing before you buy.
-
How to buy Abbott Laboratories stock (ABT)
Steps to owning and managing ABT, with 24-hour and historical pricing before you buy.
-
How to buy Pfizer stock (PFE)
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
-
How to buy Johnson & Johnson stock (JNJ)
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.
Ask a question